{"changes":[],"country":"NL","description":"Develops first-in-class small-molecule WASp modulators, including agonist BM-011 and antagonist programs. Targets patients with AML, lymphomas, leukemias and autoimmune conditions like arthritis and colitis. Dual agonist-and-antagonist platform unlocks WASp biology, licensed in from Switzerland's Institute of Oncology Research.","domain":"biminibiotech.nl","employees":null,"founded":2019,"fundingTotalQuarantined":false,"githubOrg":null,"githubStars":null,"industry":"bio","investors":[],"lat":52.159475,"lng":4.490884,"location":"Leiden, Netherlands","name":"BIMINI Biotech","rounds":[{"amountQuarantined":false,"amountUsd":3240000,"currency":"EUR","date":"2025-01-01","investors":[],"leadInvestor":null,"source":{"fact":"round","publisher":"eu-startups","retrievedAt":"2026-05-06","status":"attributed","url":null},"status":"attributed","type":"seed","url":null}],"slug":"biminibiotech-nl","sources":[{"fact":"round","publisher":"eu-startups","retrievedAt":"2026-05-06","status":"attributed","url":null},{"fact":"existence","publisher":"biminibiotech.nl","retrievedAt":"2026-05-06","status":"self-reported","url":"https://biminibiotech.nl"},{"fact":"description","publisher":"biminibiotech.nl","retrievedAt":"2026-05-06","status":"self-reported","url":"https://biminibiotech.nl"}],"stage":"seed","techStack":["PHP 7.4.33","WordPress 6.5.8","Apache HTTP Server","Mesmerize Companion 1.6.149","jQuery Migrate 3.4.1","imagesLoaded 5.0.0","ExtendThemes Mesmerize","Varnish","MySQL","jquery 3.7.1","apache"],"totalRaisedUsd":3456000,"updatedAt":"2026-05-06"}